IQ, OQ & PQ in 2026: What Now Counts as Sufficient Validation Evidence

GET YOUR INSTANT STREAMING ACCESS OF THIS COURSE

IQ, OQ & PQ: What Now Counts as Sufficient Validation Evidence

Validation expectations surrounding IQ, OQ, PQ, and PPQ activities continue to evolve as regulated companies balance scientific rigor, operational efficiency, lifecycle management, digitalized systems, and increasing regulatory scrutiny. While most organizations maintain established qualification and validation procedures, many teams still struggle with a critical question: what now constitutes sufficient and defensible validation evidence within modern globally regulated GMP environments?

In practice, validation challenges rarely arise from missing protocols alone. Regulators increasingly evaluate whether validation activities demonstrate meaningful scientific rationale, appropriate risk-based decision-making, traceable execution, and reliable evidence supporting intended system or process performance. Excessive documentation without clear value, inconsistent justification for reduced testing, weak acceptance criteria, poorly supported deviations, and fragmented validation rationale continue to create uncertainty across many organizations.

This practical 90-minute webinar examines modern expectations for IQ, OQ, PQ, and PPQ evidence within today’s GMP systems. The session will explore how organizations can distinguish between low-value validation activity and evidence that genuinely demonstrates operational control, process understanding, and defensible qualification practices.

Real-world scenarios and practical examples will be used throughout the session to help participants strengthen validation reasoning, improve evidence quality, support risk-based decision-making, and build more sustainable validation strategies aligned with evolving global GMP expectations.

| WHY YOU SHOULD ATTEND

Many validation teams continue to generate large volumes of qualification and validation documentation, yet uncertainty remains around whether the evidence produced truly supports defensible GMP decision-making. Organizations frequently struggle to determine the appropriate depth of testing, justification for reduced verification activities, management of deviations, and the level of evidence regulators expect to see within modern validation programs.

At the same time, validation approaches are becoming more risk-focused and operationally driven across global manufacturing and quality operations. Regulators increasingly assess not only whether validation activities were completed, but whether the rationale behind testing, acceptance criteria, execution strategies, and final conclusions demonstrates sound scientific and quality judgment.

This webinar provides a practical and experience-driven perspective on how IQ, OQ, PQ, and PPQ activities can be approached more effectively within modern GMP environments. Participants will better understand how to evaluate validation sufficiency, avoid low-value documentation practices, improve validation defensibility, and apply stronger critical thinking when making qualification and process validation decisions.

The session is designed to help teams build validation programs that are both operationally practical and scientifically credible.

| AREAS COVERED

• Modern global expectations for IQ, OQ, PQ, and PPQ evidence
• Determining what constitutes sufficient validation documentation
• Balancing risk, rigor, efficiency, and scientific justification
• Common weaknesses found in qualification and validation activities
• Developing meaningful acceptance criteria and testing rationale
• Managing deviations, discrepancies, and validation decision-making
• Distinguishing low-value documentation from defensible evidence
• Practical strategies for sustainable and credible validation programs

| WHO SHOULD ATTEND

• Validation and Qualification Teams
• Quality Assurance (QA) Departments
• Quality Control (QC) Departments
• Engineering Departments
• Technical Operations 
• Manufacturing Departments
• Regulatory Affairs Departments
• Process Development and Technology Transfer
• Compliance and Quality Systems Professionals

Course Director: Meredith Crabtree

Meredith Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.